We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

80 hedge funds and large institutions have $522M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

14% more capital invested

Capital invested by funds: $460M → $522M (+$62.1M)

3% more funds holding

Funds holding: 78 → 80 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
25
Reduced
26
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$30.8M
2
KCM
Kingdon Capital Management
New York
+$4.84M
3
EP
Eversept Partners
New York
+$4.73M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.54M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$4.06M

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$6.97M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$6.52M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.3M
4
EA
Emerald Advisers
Pennsylvania
-$5.75M
5
Citadel Advisors
Citadel Advisors
Florida
-$4.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$3.43M -$7.9K -302 -0.2%
Northern Trust
27
Northern Trust
Illinois
$3.13M -$113K -4,305 -3%
Hudson Bay Capital Management
28
Hudson Bay Capital Management
Connecticut
$3.05M +$3.44M +131,295 New
FI
29
Fosun International
China
$2.97M – – –
Axa
30
Axa
France
$2.92M – – –
SFM
31
Sphera Funds Management
Israel
$2.67M – – –
Deutsche Bank
32
Deutsche Bank
Germany
$2.25M +$2.28K +87 +0.1%
SA
33
Sunesis Advisors
Kansas
$2.23M – – –
Charles Schwab
34
Charles Schwab
California
$1.69M +$83.3K +3,184 +5%
Goldman Sachs
35
Goldman Sachs
New York
$1.35M +$445K +16,999 +41%
MWNA
36
Marshall Wace North America
New York
$1.34M +$1.47M +56,315 +4,025%
Alyeska Investment Group
37
Alyeska Investment Group
Illinois
$1.24M -$1.04M -39,719 -43%
Squarepoint
38
Squarepoint
New York
$1.11M +$227K +8,665 +22%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.09M +$11K +422 +0.9%
NC
40
Nexthera Capital
New York
$995K -$2.07M -79,027 -65%
CIBC Asset Management
41
CIBC Asset Management
Ontario, Canada
$958K +$1.08M +41,258 New
Rafferty Asset Management
42
Rafferty Asset Management
New York
$767K +$865K +33,032 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$636K +$20.9K +800 +3%
Bank of America
44
Bank of America
North Carolina
$580K +$37.4K +1,429 +6%
PPA
45
Parametric Portfolio Associates
Washington
$541K +$52.2K +1,995 +9%
TA
46
Teachers Advisors
New York
$482K +$93.1K +3,559 +21%
QI
47
QS Investors
New York
$474K +$534K +20,400 New
SCA
48
Secor Capital Advisors
New York
$451K +$193K +7,382 +61%
OPPM
49
Opus Point Partners Management
New York
$432K +$488K +18,631 New
SO
50
STRS Ohio
Ohio
$422K – – –
1
2
3 4

DCPH Hedge Fund Activity: Q1 2019 in Review

80 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q1 2019, worth a combined $522M — up 14% from $460M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new DCPH positions and 9 closed out — a net gain of 2 holders — while 25 added to existing stakes and 26 trimmed.

The largest buyer was OrbiMed, adding an estimated $30.8M. The largest seller was Norges Bank, exiting entirely with an estimated $6.97M sold.

  • 80 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q1 2019, up from 78 in Q4 2018.
  • Funds reported $522M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q1 2019, up 14% quarter-over-quarter.
  • 11 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q1 2019 and 9 closed out, a net change of +2 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q1 2019 was OrbiMed, an estimated $30.8M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q1 2019 was Norges Bank, an estimated $6.97M sold.

Based on aggregated 13F filings for Q1 2019.